CHRISTOPHER GRAY: Open Payments
NPI 1104468560 · GROVE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $73 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $194 |
| Amgen Inc. | 4 | $81 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $30 |
| Lilly USA, LLC | 2 | $28 |
| Organon LLC | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Dexcom G6 Transmitter, OTEZLA, UZEDY, NURTEC ODT, MOUNJARO, NEXPLANON, Kerendia, JARDIANCE.
Industry payments across OK — which companies pay providers there.
